Purchase Order 75N94025P00526
Award Date
8/27/25
Potential Completion Date
11/21/25
Potential Value
$67K
Federal Agency
National Institute of Child Health and Human Development
Awardee
Integral Molecular Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award is to Integral Molecular Inc., a biotechnology company specializing in membrane protein research and antibody development. The contract, valued at $150,000.00, was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), under the Small Business Innovation Research (SBIR) program. The contract is for a Phase I research project focused on biomedical research. It is designated as a total small business set-aside. Integral Molecular...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,500,000.00 Firm Fixed Price Definitive Contract to Integral Molecular Inc., a small business biotechnology company, for the development of antibody reagents to support immunologic analysis of underrepresented mammalian models. This contract is part of the Small Business Innovation Research (SBIR) Program Phase II. Integral Molecular specializes in membrane protein research and has received prior contracts and grants...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $16,200 purchase order to Integral Molecular Inc. for membrane proteome array services (AMBIS #2194825). The firm fixed price contract will be performed in Philadelphia, Pennsylvania from November 21, 2023 through January 31, 2024. As part of NIH's efforts to advance biomedical research, this award will provide Integral Molecular services to analyze protein...
This is a $600,000 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Integral Molecular Inc., a biotechnology company specializing in membrane protein research and therapeutic antibody development. The contract is for the development of "Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian Models", supporting...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $5,000 purchase order to Proteinsimple, a division of Bio-Techne Corporation doing business as Bio-Techne, to provide unspecified services. The one-year contract runs from December 2016 through December 2017 and utilizes a firm fixed price payment structure. The place of performance is Bethesda, Maryland, where NICHD is headquartered. No additional...
The National Institutes of Health's National Institute of Child Health and Human Development awarded a $15,000 purchase order to Biognosys AG of Switzerland to provide proteome profiling services for patients with central conducting lymphatic anomaly. Under this firm fixed price contract, Biognosys will utilize its expertise in proteomics to analyze protein expression patterns in patient samples over the one year period of performance. As the prime contractor, Biognosys will leverage its...
Integral Molecular Inc. has been awarded a $20,000 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. This contract has no set-aside designation. The contract is for MPA+IND SCREEN services to support the National Cancer Institute's screening and research programs. As a biotechnology company focused on membrane proteins and disease targets, Integral Molecular will likely provide biological materials, testing,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $600,000 firm-fixed-price definitive contract to Integral Molecular Inc., a small business biotechnology company, for "ADJUVANT TARGET DISCOVERY FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASES." The contract has a completion date of June 29, 2024. Integral Molecular specializes in membrane protein research and has received numerous federal contracts and grants from agencies like the National Institutes of...
The National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services, awarded a $25,376.40 firm-fixed-price purchase order to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., for the supply of three units of ProcartaPlex HU IMMUNE RESPONSE 80PLEX 96 TESTS immunoassay plates compatible with the Luminex xMAP INTELLIFLEX platform. This acquisition supports the NICHD's research capabilities in high-throughput multiplex...
The National Institutes of Health's National Institute of Child Health and Human Development awarded a $21,435 firm fixed price purchase order to Advanced Cell Diagnostics, Inc., doing business as ACD, a subsidiary of Bio-Techne Corporation, also doing business as Bio-Techne. The contract is for the delivery of RNAscope reagents, kits, and specific probes to support NICHD's research efforts. As the leading federal sponsor of biomedical research, NIH aims to uncover new knowledge that will lead...